Drug intelligence / Profile preview

lindane

Development stage
Unknown
Modality
Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Lindane is an organochlorine insecticide and ectoparasiticide used as a second-line topical treatment for scabies and lice infestations in humans. It is available as a cream or lotion for scabies and as a shampoo for lice. Lindane acts by blocking the Gamma-aminobutyric acid type A receptor (GABA_A receptor)-chloride channel complex in parasites (and humans), leading to neuronal hyperexcitation and death of the parasite. Due to its neurotoxicity risk—including seizures and rare fatalities—lindane is reserved for patients who cannot tolerate or have failed safer first-line therapies such as permethrin. Lindane has been banned or restricted in many countries due to environmental concerns and toxicity but remains FDA-approved in the United States for limited use[1][2][3][4][5][7].

Brand names
KwellThionex
Other names
lindanegamma benzene hexachloridegamma-hexachlorocyclohexaneγ-HCHgammaxeneGammallinbenzene hexachlorideBHC
02

Targets

Glycine receptorGABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on lindane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lindane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call